The MicroArray Quality Control (MAQC) Project Shows Inter- and Intraplatform Reproducibility of Gene Expression Measurements

National Center for Toxicological Research, US Food and Drug Administration, Jefferson, Arkansas 72079, USA.
Nature Biotechnology (Impact Factor: 41.51). 10/2006; 24(9):1151-61. DOI: 10.1038/nbt1239
Source: PubMed


Over the last decade, the introduction of microarray technology has had a profound impact on gene expression research. The publication of studies with dissimilar or altogether contradictory results, obtained using different microarray platforms to analyze identical RNA samples, has raised concerns about the reliability of this technology. The MicroArray Quality Control (MAQC) project was initiated to address these concerns, as well as other performance and data analysis issues. Expression data on four titration pools from two distinct reference RNA samples were generated at multiple test sites using a variety of microarray-based and alternative technology platforms. Here we describe the experimental design and probe mapping efforts behind the MAQC project. We show intraplatform consistency across test sites as well as a high level of interplatform concordance in terms of genes identified as differentially expressed. This study provides a resource that represents an important first step toward establishing a framework for the use of microarrays in clinical and regulatory settings.

Download full-text


Available from: Timothy S Davison, Nov 19, 2015
    • "subtle changes in expression of key genes (Black et al., 2014). Large evaluation efforts have shown that there is still no combination of experimental and analytical methodologies that ensures a reproducible detection of small-magnitude differential expression (Shi et al., 2006;Su et al., 2014). This may impose undesirable constraints to dosage in HTS/ HCA studies with ENPs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Engineered Nanoparticles (ENPs) present novel/added challenges to the established effect assessment modus operandi, requiring an update of used methods. ENPs are dimensionally and physically different from conventional chemicals, which imply that the metrics with which we relate effect and the type of effect responses are different from that of the conventional approach. Effects on organisms are often preceded by changes on the sub-organismal level (cell, genes), dedicated tools have vast potential to detect earlier (and link to) effects on higher levels of organization. High-throughput screening (HTS) is rapid, cost-effective and specific. One way forward is to link HTS to population outcomes, targeting a systems toxicology approach. Although the benefits of integrating various levels of information may seem obvious, this is an even more decisive aspect when rapid answers are needed for ENPs. Here we rank the available tools/methods, highlight main study gaps and list priority needs and the way forward.
    No preview · Article · Nov 2015 · Environmental Pollution
  • Source
    • "Today, the most broadly used platforms are DNA microarrays and quantitative real-time PCR, although RNA sequencing is gaining popularity. Extensive work in this fi eld has demonstrated that although these platforms have varying degrees of sensitivity, the data produced from one platform are generally quite reproducible on another (e.g., Shi et al. 2006, Yauk and Berndt 2007). The type of data processing (i.e., background subtraction, fi ltering, and normalization ) applied for the analysis of gene expression data can impact the genes identifi ed as diff erentially expressed and the magnitude of the fold change (Steinhoff and Vingron 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract The use of short-term toxicogenomic tests to predict cancer (or other health effects) offers considerable advantages relative to traditional toxicity testing methods. The advantages include increased throughput, increased mechanistic data, and significantly reduced costs. However, precisely how toxicogenomics data can be used to support human health risk assessment (RA) is unclear. In a companion paper ( Moffat et al. 2014 ), we present a case study evaluating the utility of toxicogenomics in the RA of benzo[a]pyrene (BaP), a known human carcinogen. The case study is meant as a proof-of-principle exercise using a well-established mode of action (MOA) that impacts multiple tissues, which should provide a best case example. We found that toxicogenomics provided rich mechanistic data applicable to hazard identification, dose-response analysis, and quantitative RA of BaP. Based on this work, here we share some useful lessons for both research and RA, and outline our perspective on how toxicogenomics can benefit RA in the short- and long-term. Specifically, we focus on (1) obtaining biologically relevant data that are readily suitable for establishing an MOA for toxicants, (2) examining the human relevance of an MOA from animal testing, and (3) proposing appropriate quantitative values for RA. We describe our envisioned strategy on how toxicogenomics can become a tool in RA, especially when anchored to other short-term toxicity tests (apical endpoints) to increase confidence in the proposed MOA, and emphasize the need for additional studies on other MOAs to define the best practices in the application of toxicogenomics in RA.
    Full-text · Article · Jan 2015 · Critical Reviews in Toxicology
  • Source
    • "Quality control was performed using log-ratio versus log-product (MA) plots and volcano plots (data not shown). Probes with a substantial likelihood of differential expression under treatment conditions were identified using simple t-tests combined with mean fold change in accordance with recommendations from the Microarray Quality Control Consortium (Guo et al. 2006; Shi et al. 2006). We selected a t-test p-value threshold of 0.1 and a minimum absolute fold difference of 2.0 between the controls and exposed data sets. "
    [Show abstract] [Hide abstract]
    ABSTRACT: There is a growing recognition that the toxic effects of chemical mixtures are been an important issue in toxicological sciences. Tributyltin (TBT) and Benzo[a]pyrene (BaP) are widespread pollutants that occur simultaneously in the aquatic environments. This study was designed to examine comprehensively the combined effects of TBT and BaP on zebrafish (Danio rerio) embryos using toxicogenomic approach combined with biochemical detection and morphological analysis, and tried to gain insight into the mechanisms underlying the combined effects of TBT and BaP. The results of toxicogenomic data indicated that: 1) TBT cotreatment rescued the embryos from decreased hatching ratio caused by BaP alone, while the alteration of gene expression (in this article the phrase gene expression is used as a synonym to gene transcription, although in is acknowledged that gene expression can also be regulated by, e.g., translation and mRNA or protein stability) relative to zebrafish hatching in the BaP groups was resumed by the cotreatment with TBT; 2) BaP cotreatment decreased TBT-mediated dorsal curvature, and alleviated the perturbation of Notch pathway caused by TBT alone; 3) cotreatment with TBT decreased BaP-mediated bradycardia, which might be due to that TBT cotreatment alleviated the perturbation in expression of genes related to cardiac muscle cell development and calcium handling caused by BaP alone; 4) TBT cotreatment brought an antagonistic effect on the BaP-mediated oxidative stress and DNA damage. These results suggested that toxicogenomic approach was available for analyzing combined toxicity with high sensitivity and accuracy, which might improve our understanding and predictability for the combined effects of chemicals.
    Full-text · Article · Nov 2014 · Aquatic Toxicology
Show more